You are viewing the site in preview mode
Skip to main content
| |
Low CEA
|
High CEA
|
|---|
|
NO
|
Author
|
Year of publication
|
No. of patients
|
CEA cut-off
|
No. of LN
|
5 year survival
|
Recurrence
|
No. of LN
|
5 year survival
|
Recurrence
|
|---|
|
1
|
Ryo Maeda [29]
|
2017
|
378
|
5 ng/mL
|
263 N0, 15 N1–3
|
87.70%
| |
81 N0, 19 N1–3
|
75.50%
| |
|
2
|
Yusuke Takahashi [30]
|
2015
|
171
|
5 ng/mL
| | | | | | |
|
3
|
Gianfranco Buccheri [18]
|
2003
|
118
|
10 ng/mL
| | |
16%
| | |
70%
|
|
4
|
Riken Kawachi [31]
|
2009
|
815
|
5 ng/mL
| |
76.70%
| | |
56.60%
| |
|
5
|
Niels Reinmuth [19]
|
2002
|
67
|
5 ng/mL
| | | | | | |
|
6
|
Sukki Cho [32]
|
2013
|
770
|
3.5 ng/mL (mean)
| | | | | | |
|
7
|
Kaoru Kaseda [33]
|
2016
|
246
|
5 ng/mL
|
168 N0, 19 N1-N2
| | |
47 N0, 12 N1-N2
| | |
|
8
|
Tatsuya Kato [34]
|
2013
|
177
|
3 ng/mL
| |
93.2% (ADC), 81% (SCC)
|
6.80%
| |
59.4% (ADC), 51.9% (SCC)
|
38.80%
|
|
9
|
Terumoto Koike [35]
|
2012
|
894
|
5 ng/mL
| | | | | | |
|
10
|
Hiroaki Komatsu [36]
|
2013
|
279
|
2.8 ng/mL
|
87 N0, 1 skip N2
| | |
143 N0, 11 skip N2
| | |
|
11
|
Yasuhiro Tsutani [37]
|
2014
|
100
|
2.5 ng/mL
| | | | | | |
|
12
|
Bo Ye [38]
|
2014
|
651
|
5 ng/mL
|
371 N0, 11 N1, 8 N2
| | |
211 N0, 32 N1,18 N2
| | |